GB202103551D0 - In vivo delivery - Google Patents

In vivo delivery

Info

Publication number
GB202103551D0
GB202103551D0 GBGB2103551.4A GB202103551A GB202103551D0 GB 202103551 D0 GB202103551 D0 GB 202103551D0 GB 202103551 A GB202103551 A GB 202103551A GB 202103551 D0 GB202103551 D0 GB 202103551D0
Authority
GB
United Kingdom
Prior art keywords
vivo delivery
vivo
delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2103551.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nuntius Therapeutics Ltd
Original Assignee
Nuntius Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nuntius Therapeutics Ltd filed Critical Nuntius Therapeutics Ltd
Publication of GB202103551D0 publication Critical patent/GB202103551D0/en
Priority to EP22708035.5A priority Critical patent/EP4284438A1/en
Priority to KR1020237028688A priority patent/KR20230138490A/en
Priority to AU2022212598A priority patent/AU2022212598A1/en
Priority to US18/274,869 priority patent/US20240108753A1/en
Priority to CA3206711A priority patent/CA3206711A1/en
Priority to CN202280022106.4A priority patent/CN117460537A/en
Priority to PCT/EP2022/052145 priority patent/WO2022162200A1/en
Priority to JP2023546009A priority patent/JP2024505924A/en
Ceased legal-status Critical Current

Links

GBGB2103551.4A 2021-01-29 2021-03-15 In vivo delivery Ceased GB202103551D0 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
EP22708035.5A EP4284438A1 (en) 2021-01-29 2022-01-28 Nucleic acid delivery
KR1020237028688A KR20230138490A (en) 2021-01-29 2022-01-28 Nucleic acid delivery
AU2022212598A AU2022212598A1 (en) 2021-01-29 2022-01-28 Nucleic Acid Delivery
US18/274,869 US20240108753A1 (en) 2021-01-29 2022-01-28 Nucleic acid delivery
CA3206711A CA3206711A1 (en) 2021-01-29 2022-01-28 Nucleic acid delivery
CN202280022106.4A CN117460537A (en) 2021-01-29 2022-01-28 Nucleic acid delivery
PCT/EP2022/052145 WO2022162200A1 (en) 2021-01-29 2022-01-28 Nucleic Acid Delivery
JP2023546009A JP2024505924A (en) 2021-01-29 2022-01-28 nucleic acid delivery

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2101301.6A GB202101301D0 (en) 2021-01-29 2021-01-29 In vivo delivery

Publications (1)

Publication Number Publication Date
GB202103551D0 true GB202103551D0 (en) 2021-04-28

Family

ID=74865203

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB2101301.6A Ceased GB202101301D0 (en) 2021-01-29 2021-01-29 In vivo delivery
GBGB2103551.4A Ceased GB202103551D0 (en) 2021-01-29 2021-03-15 In vivo delivery

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GBGB2101301.6A Ceased GB202101301D0 (en) 2021-01-29 2021-01-29 In vivo delivery

Country Status (1)

Country Link
GB (2) GB202101301D0 (en)

Also Published As

Publication number Publication date
GB202101301D0 (en) 2021-03-17

Similar Documents

Publication Publication Date Title
HK1254958A1 (en) Prosthetic heart valve and delivery apparatus
IL272534A (en) Anthracycline-based antibody drug conjugates having high in vivo tolerability
EP3781196C0 (en) Sequence-specific in vivo cell targeting
ZA201302900B (en) Peptide-based in vivo sirna delivery system
IL208708A0 (en) Carbidopa/lipodopa gastroretentive drug delivery
EP2339973A4 (en) Drug delivery implants
EP2419050A4 (en) Vascular implant and delivery system
SG2014007389A (en) Posterior segment drug delivery
RS62459B1 (en) In vivo drug delivery devices
EP2323587A4 (en) Drug delivery implants
GB2563875B (en) Improvements in drug delivery
GB202020129D0 (en) Content delivery
EP2328511A4 (en) Drug delivery implants
GB2586637B (en) Content delivery
IL287330A (en) Hydrogel drug delivery composition
GB2598295B (en) Content delivery
GB202103551D0 (en) In vivo delivery
GB2591196B (en) Improvements in needle-free delivery
GB202108686D0 (en) Game delivery system
EP3601261A4 (en) Protease-activated contrast agents for in vivo imaging
GB2611515B (en) Content delivery
GB202108737D0 (en) Improvements in delivery packaging
GB201905298D0 (en) Improvements in delivery devices
GB202105926D0 (en) Improvements in dentistry
GB202105927D0 (en) Improvements in dentistry

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)